Cell Source Availability

Cell Source Availability is a scholarly construct in the domain of biomedical research that denotes the extent to which a particular cell type or lineage can be accessed, obtained, and utilized for experimental or therapeutic purposes under defined biological, ethical, and logistical constraints.

57

Publications

3.3K

Citations

372

Authors

133

Institutions

Publications per year

2017–2026

16

Authors

372

  1. MG
    Michael G. Fehlings

    University of Toronto, Canada

    2 publications · 147 citations

    2

    h-index

  2. IM
    Igor M. Sauer

    Charité - Universitätsmedizin Berlin, Germany

    2 publications · 216 citations

    2

    h-index

  3. RP
    Ryan P. Salewski

    University of Toronto, Canada

    2 publications · 147 citations

    2

    h-index

  4. RA
    Robert A. Mitchell

    University of Louisville, United States

    2 publications · 147 citations

    2

    h-index

  5. GV
    Gordana Vunjak‐Novakovic

    Columbia University, United States

    1 publications · 17 citations

    1

    h-index

1–5 of 372

Venues

  1. Stem Cells and Development

    4 publications · 220 citations

    4

    h-index

  2. PubMed

    Repository · 4 publications · 67 citations

    4

    h-index

  3. Regenerative Medicine

    2 publications · 32 citations

    2

    h-index

  4. The International Journal of Artificial Organs

    2 publications · 166 citations

    2

    h-index

  5. PLoS Pathogens

    1 publications · 45 citations

    1

    h-index

1–5